Pesquisas alternativas:
dosev » doses (Expandir a Pesquisa), dosen (Expandir a Pesquisa), dosel (Expandir a Pesquisa), dosv (Expandir a Pesquisa)
dosed » doses (Expandir a Pesquisa), posed (Expandir a Pesquisa), dosd (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
devel » devem (Expandir a Pesquisa)
ther* » them* (Expandir a Pesquisa)
dosev » doses (Expandir a Pesquisa), dosen (Expandir a Pesquisa), dosel (Expandir a Pesquisa), dosv (Expandir a Pesquisa)
dosed » doses (Expandir a Pesquisa), posed (Expandir a Pesquisa), dosd (Expandir a Pesquisa)
dose » dos (Expandir a Pesquisa)
devel » devem (Expandir a Pesquisa)
ther* » them* (Expandir a Pesquisa)
1
Por Gavazzoni, Mara, Gorga, Elio, Derosa, Giuseppe, Maffioli, Pamela, Metra, Marco, Raddino, Riccardo
Publicado no Drug Des Devel Ther (2017)
“...BACKGROUND AND AIM: Clinical benefits of early high-dose statin therapy after acute coronary...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Belik, Ekaterina, Dyleva, Yulia, Karetnikova, Victoria
Publicado no Drug Des Devel Ther (2015)
“..., resulted in a decrease in free fatty acid levels. The positive effect of low-dose atorvastatin (20 mg/day...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Pala, Şehmus, Atilgan, Remzi, Ozkan¹, Zehra Sema, Kavak, Salih Burçin, Ilhan, Nevin, Akpolat, Nusret, Sapmaz, Ekrem
Publicado no Drug Des Devel Ther (2015)
“...). CONCLUSION: Tamoxifen 1 g and 3 g resulted in a dose-dependent increase in VEGF and endothelin 1 levels...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Zhang, Yi, Pan, Si-Yuan, Zhou, Shu-Feng, Wang, Xiao-Yan, Sun, Nan, Zhu, Pei-Li, Chu, Zhu-Sheng, Yu, Zhi-Ling, Ko, Kam-Ming
Publicado em 2014
“... fructus (SF). This study was conducted to compare the time- and dose-response between Sch B- and SF oil...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Zhu, Sheng, Yang, Yu-Hui, Gao, Rong-Wei, Li, Ran, Zou, Yu-Zhen, Feng, Lei, Zhang, Bo
Publicado no Drug Des Devel Ther (2017)
“... alkaline phosphatase (ALP) level was 279.50 (137–548) U/L, which was significantly higher than the normal...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“... days, following an initial 20 mg loading dose. Efficacy was evaluated by the magnitude and extent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Yu, Wei, Ji, Jinru, Xiao, Tingting, Ying, Chaoqun, Fang, Jiaheng, Shen, Ping, Xiao, Yonghong
Publicado no Drug Des Devel Ther (2017)
“... level of toxicity. The objective of this study was to obtain optimal dosing regimen of oral...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Gozzard, David
Publicado em 2011
“... and its treatment. The literature indicates that high doses of iron are required, with levels of 1500 mg...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Kovács, Diána, Simon, Zoltán, Hári, Péter, Málnási-Csizmadia, András, Hegedűs, Csaba, Drimba, László, Németh, József, Sári, Réka, Szilvássy, Zoltán, Peitl, Barna
Publicado em 2013
“... previously unknown therapeutic effects of generic drugs. Nitazoxanide can be the prototype chemical structure...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Kim, Hyungsub, Choi, Hee Youn, Kim, Yo-Han, Bae, Kyun-Seop, Jung, Jina, Son, Hankil, Lim, Hyeong-Seok
Publicado no Drug Des Devel Ther (2018)
“... that effectively reduces low-density lipoprotein cholesterol levels. However, statin monotherapy does not always...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Chen, Laishun, Greenberg, William M, Brand-Schieber, Elimor, Wangsa, Julie, Periclou, Antonia, Ghahramani, Parviz
Publicado no Drug Des Devel Ther (2015)
“... participant received one dose of levomilnacipran ER 40 mg. Blood and urine were assayed using liquid...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Gu, Namyi, Park, Min Kyu, Kim, Tae-Eun, Bahng, Mi Young, Lim, Kyoung Soo, Cho, Sang-Heon, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin, Yu, Kyung-Sang
Publicado em 2014
“..., placebo-controlled, multiple-dose, dose-escalation study was performed in a total of 30 subjects. Repeated...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“.... In this study, we attempted to increase inhaled corticosteroid (ICS) doses initially in suboptimally controlled...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Kuca, Kamil, Karasova, Jana Zdarova, Soukup, Ondrej, Kassa, Jiri, Novotna, Eva, Sepsova, Vendula, Horova, Anna, Pejchal, Jaroslav, Hrabinova, Martina, Vodakova, Eva, Jun, Daniel, Nepovimova, Eugenie, Valis, Martin, Musilek, Kamil
Publicado no Drug Des Devel Ther (2018)
“... of currently used drugs led to research of novel potent molecules for prophylaxis of organophosphorus...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Soni, Kiran Kumar, Kim, Hye Kyung, Choi, Bo Ram, Karna, Keshab Kumar, You, Jae Hyung, Cha, Jai Seong, Shin, Yu Seob, Lee, Sung Won, Kim, Chul Young, Park, Jong Kwan
Publicado no Drug Des Devel Ther (2016)
“... by increasing its dose over a constant time period. Sprague Dawley rats were divided into five treatment groups...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Suh, Hoon Young, Peck, Carl C, Yu, Kyung-Sang, Lee, Howard
Publicado no Drug Des Devel Ther (2016)
“... biological effect level (MABEL)- or minimum effective dose (MED)-based approach was used more frequently...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Yovich, John L, Alsbjerg, Birgit, Conceicao, Jason L, Hinchliffe, Peter M, Keane, Kevin N
Publicado no Drug Des Devel Ther (2016)
“...The first PIVET algorithm for individualized recombinant follicle stimulating hormone (rFSH) dosing...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Cheng, Shih-Lung, Su, Kang-Cheng, Wang, Hao-Chien, Perng, Diahn-Warng, Yang, Pan-Chyr
Publicado em 2014
“... disease (COPD) receiving inhaled corticosteroid (ICS) therapy have been documented. The aim of this study...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Martin-Martin, LS, Giovannangeli, F, Bizzi, E, Massafra, U, Ballanti, E, Cassol, M, Migliore, A
Publicado no Drug Des Devel Ther (2017)
“... patients were enrolled and randomized to continue disease-modifying antirheumatic drugs (DMARDs) therapy...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo